comprehensive -WSS

comprehensive

author：focus 2025-10-02 19:21:11 - browse：7

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： CDC picks Alphabet's Verily for wasterwater surveillance contract

WSS

Democrats decry new health bill for going easy on private equity

Will the FTC rein in IQVIA's health data empire?

Flu, Covid vaccination rates decline, new survey data show

The Karikó problem: Lessons for funding basic research

RSV injection headlines need to be accurate for good uptake

In the gardens at Boston Children's Hospital, families find sanctuary

explore

comprehensive

hotspot

What does generative AI mean for health care? We asked experts

Former reverend arrested for allegedly killing 8

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare innovation center doesn’t save money, experts say

In Memoriam: Notable people who died in 2023

European officials brace for rough respiratory virus season

Alkermes shareholders re

European officials brace for rough respiratory virus season

Hepatitis C has a cure — but many Americans still lack access to it

Truvian presents data for its desktop blood

explore

Will the FTC rein in IQVIA's health data empire?

Biden warns of ‘dark winter’ during final presidental debate

RSV injection headlines need to be accurate for good uptake

What to watch for from Zogenix and Amicus clinical trials

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Democrats decry new health bill for going easy on private equity

focus

leisure time

entertainment

leisure time